ODI Pharma AB (publ) (NGM: ODI)
Sweden
· Delayed Price · Currency is SEK 2.760
0.00 (0.00%)
At close: Dec 20, 2024
ODI Pharma AB Income Statement
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
| Revenue | 22.06 | 22.29 | 0.14 | 0.31 | - | - | Upgrade
|
| Revenue Growth (YoY) | 3349.15% | 15880.34% | -55.44% | - | - | - | Upgrade
|
| Cost of Revenue | 17.19 | 17.66 | 0.86 | 0.42 | - | - | Upgrade
|
| Gross Profit | 4.87 | 4.62 | -0.72 | -0.1 | - | - | Upgrade
|
| Selling, General & Admin | 6.47 | 6.54 | 6.09 | 7.12 | 3.92 | 4.7 | Upgrade
|
| Other Operating Expenses | -2.71 | -2.35 | -0 | -0.02 | 0.04 | 0.22 | Upgrade
|
| Operating Expenses | 3.77 | 4.19 | 6.09 | 7.1 | 3.96 | 4.93 | Upgrade
|
| Operating Income | 1.11 | 0.43 | -6.81 | -7.21 | -3.96 | -4.93 | Upgrade
|
| Interest Expense | -0.76 | -0.86 | -0.11 | -0.03 | -0.01 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.17 | 0.05 | 0.02 | 0 | 0.01 | 0 | Upgrade
|
| Pretax Income | 0.52 | -0.38 | -6.9 | -7.24 | -3.97 | -4.94 | Upgrade
|
| Income Tax Expense | 0.19 | 0.19 | 0.01 | 0 | 0.01 | 0.02 | Upgrade
|
| Net Income | 0.33 | -0.57 | -6.9 | -7.24 | -3.98 | -4.96 | Upgrade
|
| Net Income to Common | 0.33 | -0.57 | -6.9 | -7.24 | -3.98 | -4.96 | Upgrade
|
| Shares Outstanding (Basic) | 15 | 15 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 15 | 15 | 15 | 15 | 15 | 14 | Upgrade
|
| Shares Change (YoY) | -0.76% | -0.76% | 1.69% | -1.52% | 11.10% | 10.04% | Upgrade
|
| EPS (Basic) | 0.02 | -0.04 | -0.45 | -0.48 | -0.26 | -0.36 | Upgrade
|
| EPS (Diluted) | 0.02 | -0.04 | -0.45 | -0.48 | -0.26 | -0.36 | Upgrade
|
| Free Cash Flow | -0.22 | -3.82 | -5.1 | -7.38 | -6.06 | -4.77 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.25 | -0.33 | -0.49 | -0.40 | -0.35 | Upgrade
|
| Gross Margin | 22.08% | 20.74% | - | -33.12% | - | - | Upgrade
|
| Operating Margin | 5.02% | 1.92% | -4884.20% | -2302.98% | - | - | Upgrade
|
| Profit Margin | 1.50% | -2.55% | -4948.58% | -2313.25% | - | - | Upgrade
|
| Free Cash Flow Margin | -1.01% | -17.16% | -3659.83% | -2357.80% | - | - | Upgrade
|
| EBITDA | 1.11 | 0.43 | -6.81 | -7.2 | -3.96 | -4.92 | Upgrade
|
| EBITDA Margin | 5.03% | 1.93% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | Upgrade
|
| EBIT | 1.11 | 0.43 | -6.81 | -7.21 | -3.96 | -4.93 | Upgrade
|
| EBIT Margin | 5.02% | 1.92% | - | - | - | - | Upgrade
|
| Revenue as Reported | 25.14 | 25.33 | 0.18 | 0.4 | 0.02 | 0.01 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.